TMS Co

TMS Co PP&E per Employee

The PP&E per Employee of TMS Co (4891.T) as of Nov 4, 2026 is 867,285.71 JPY. In the previous year, PP&E per Employee was 314,928.57 JPY — a change of 175.39% (higher).

PP&E per Employee

867,285.71JPY

YoY

175.39%

Last updated:

PP&E per Employee of TMS Co is 2023 867,285.71 JPY. PP&E per Employee of TMS Co was 2022 314,928.57 JPY. It decreases by 175.39% higher compared to the previous year.

The TMS Co PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2021
26,214.29 JPY
Jan 1, 2022
314,928.57 JPY
Jan 1, 2023
867,285.71 JPY
The TMS Co PP&E per Employee history
YEARPP&E per EmployeeYoY
867,285.71JPY+175.39%
314,928.57JPY+1,101.36%
26,214.29JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

TMS Co Stock analysis

What does TMS Co do? TMS Co., Ltd. generates revenue through the research and development of pharmaceutical products and medical devices, focusing on drug candidates targeting soluble epoxide hydrolase (sEH). The company develops sEH inhibitors for inflammatory diseases, with its lead candidate TMS-007 undergoing clinical development for acute cerebral infarction. TMS-007 combines anti-inflammatory and thrombolytic effects by inhibiting sEH and acting on plasminogen. The follow-on product TMS-008 is in pre-clinical studies for various inflammatory diseases. The company collaborates with academia and research institutions for R&D results, leveraging external research to advance its pipeline. TMS Co., Ltd. targets the pharmaceutical market for inflammatory disease treatments, focusing on drug candidates with dual mechanisms of action. Its primary customers are pharmaceutical companies and research institutions seeking innovative therapeutic solutions. The company's pipeline includes TMS-007 for acute cerebral infarction and TMS-008 for broader inflammatory conditions, positioning itself in the biopharmaceutical segment. The firm's revenue model relies on advancing its pipeline through clinical and pre-clinical stages, with potential partnerships for further development and commercialization. TMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TMS Co stock

PP&E per Employee of TMS Co is 867,285.71 JPY in 2023.

PP&E per Employee of TMS Co changed from 314,928.57 JPY to 867,285.71 JPY, representing a 175.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee TMS Co since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's TMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — TMS Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — TMS Co